Ahizechukwu C. Eke
- Johns Hopkins University · Obstetrics & Gynecology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #16,030
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15087847Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Obstetrics & Gynecology
NIH Funding · FY2026
Linked Award Amount
$1.2M
Full award amounts, FY2026
Award Records
7
Records listing this PI
Award-Linked Rank
#16,030
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Ahizechukwu C. Eke as a PI. Multi-PI records show the full award amount for context.
- 5DP1HD115433-03DP1Contact PIIntegrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir (TLD)Johns Hopkins University · Obstetrics & Gynecology (NIH department code)$426.5Kaward amount
- 1R01HL182418-01A1R01Contact PILongitudinal Assessment of Cardiometabolic Outcomes in Women Living with HIV on Dolutegravir-Based Antiretroviral Therapy Across the LifespanJohns Hopkins University · Obstetrics & Gynecology (NIH department code)$366.9Kaward amount
- 3R01HL182418-01A1S2R01Contact PILongitudinal Assessment of Cardiometabolic Outcomes in Women Living with HIV on Dolutegravir-Based Antiretroviral Therapy Across the LifespanJohns Hopkins University · Obstetrics & Gynecology (NIH department code)$198.7Kaward amount
- 3R01HL182418-01A1S1R01Contact PILongitudinal Assessment of Cardiometabolic Outcomes in Women Living with HIV on Dolutegravir-Based Antiretroviral Therapy Across the LifespanJohns Hopkins University · Obstetrics & Gynecology (NIH department code)$99.8Kaward amount
- 3DP1HD115433-03S1DP1Contact PIIntegrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir (TLD)Johns Hopkins University · Obstetrics & Gynecology (NIH department code)$75.1Kaward amount
- 3DP1HD115433-03S2DP1Contact PIIntegrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir (TLD)Johns Hopkins University · Obstetrics & Gynecology (NIH department code)$38.9Kaward amount
- 3DP1HD115433-03S3DP1Contact PIIntegrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir (TLD)Johns Hopkins University · Obstetrics & Gynecology (NIH department code)$32.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Ahizechukwu C. Eke as a PI.
FY2026 award administered by Johns Hopkins University (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardJohns Hopkins University
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Ahizechukwu C. Eke.